Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2005
09/08/2005DE19956400B4 Therapeutisch wirksame Zusammensetzung, ein Verfahren zu ihrer Herstellung und ihre Verwendung Therapeutically effective composition, a process for their preparation and their use
09/07/2005EP1571582A2 System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
09/07/2005EP1571147A2 Pyrazole analogs acting on cannabinoid receptors
09/07/2005EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/07/2005EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists
09/07/2005EP1570860A1 Antagonist and agonist binding to strong binding site of chemokine receptor
09/07/2005EP1570846A1 The novel coumarin-amide derivatives and its preparation, said drug composition and its use
09/07/2005EP1570752A1 Verwendung von ungesättigten Fettsäuren zur Verringerung des Appetits oder der Essensaufnahme
09/07/2005EP1569916A1 Substituted aralkyl derivatives
09/07/2005EP1569915A2 Spirocyclic ureas, compositions containing such compounds and methods of use
09/07/2005EP1569904A1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity
09/07/2005EP1569897A1 Substituted tetralins and indanes
09/07/2005EP1569692A2 Betaine and salicylic acid compositions
09/07/2005EP1569682A2 Combination treatment using exendin-4 and thiazolidinediones
09/07/2005EP1569680A2 Treatment of diabetes
09/07/2005EP1569673A1 Novel exendin agonist formulations and methods of administration thereof
09/07/2005EP1569667A1 Cholesterol-lowering preparation, food supplement and foodstuff, and methods for preparing same
09/07/2005EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP1569635A1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
09/07/2005EP1569634A2 Use of a pparalpha agonist and metformin for decreasing the serum triglycerides
09/07/2005EP1501834B1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
09/07/2005EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
09/07/2005EP1458717B1 Aroyl pyridinones
09/07/2005EP1401839B1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta [a] naphthalene
09/07/2005EP1370279B1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
09/07/2005EP1328519B1 Orally active salts with tyrosine kinase activity
09/07/2005EP1307438B1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
09/07/2005EP1280801B1 Hydantoin-containing glucokinase activators
09/07/2005EP1196195B1 Use of a fatty acid derivate in nasogastric enteral formulations
09/07/2005EP1178794B1 Use of succinic acid derivatives to obtain a medicine for treating inflammation
09/07/2005EP1013278B1 The extract of pine needle and the use thereof
09/07/2005EP0917537B1 Novel parathyroid hormone-related peptide analogs
09/07/2005CN1665929A Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription
09/07/2005CN1665836A Phosphoinositolglycan (PIG)-binding protein from adipocytes
09/07/2005CN1665822A 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665815A Novel tetracyclo-aryl-carbonyl indoles used as therapeutical agents with 5-hydroxy-tryptamine receptor affinity, their preparation process and pharmaceutical compounds containing same
09/07/2005CN1665812A Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity
09/07/2005CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
09/07/2005CN1665791A Quinazoline derivatives
09/07/2005CN1665786A Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof
09/07/2005CN1665785A 2-cyano-4-fluoropyrrolidine derivative or its salt
09/07/2005CN1665783A Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665566A Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium c
09/07/2005CN1665565A GHRELIN-carrier conjugates
09/07/2005CN1665554A Compounds and method for coating surfaces in a haemocompatible manner
09/07/2005CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents
09/07/2005CN1665536A Use of CETP inhibitors and antihypertensive agents as well as optionally HMG COA reductase inhibitors
09/07/2005CN1665521A Purified amylase inhibitor and novel process for obtaining the same
09/07/2005CN1665520A Herbal product to be administered to diabetic individuals and the production method thereof
09/07/2005CN1665512A Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases
09/07/2005CN1665502A MCHIR antagonists
09/07/2005CN1665499A Drug composition for prevention or inhibition of advance of diabetic complication
09/07/2005CN1665498A Drug composition for blood sugar control
09/07/2005CN1665493A Hypoglycemic agent, liver protecting agent and anticancer agent containing lignans originating in hongdoushan
09/07/2005CN1665404A Satiety inducing composition
09/07/2005CN1663613A Recombinant protein and recombinant gene capable of preventing and curing I type diabetes mellitus through immunity
09/07/2005CN1663594A Blood fat-decreasing weight-reducing kaladana capsule
09/07/2005CN1663571A Polysaccharide biological calcium and its preparation
09/07/2005CN1663561A Use of rare earth element salt in preparation of insulin beta cell for treating diabetes
09/07/2005CN1217939C Compound of phycocyania of blue-green algae, its preparing method and usage
09/07/2005CN1217938C Bis-arylsulfones
09/07/2005CN1217936C Heterocyclic compounds having sulfonamide
09/07/2005CN1217927C Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
09/07/2005CN1217926C Novel vitamin D analogues
09/07/2005CN1217918C Aminocyclohexyl ether compounds and uses thereof
09/07/2005CN1217671C Fish brain oil and method for extracting it
09/07/2005CN1217658C Organic bio-iodine and its use
09/06/2005US6939992 Polymorphic forms of sertraline hydrochloride
09/06/2005US6939891 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
09/06/2005US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1)
09/06/2005US6939880 Compounds with growth hormone releasing properties
09/06/2005US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders
09/06/2005US6939867 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents
09/06/2005US6939858 For therapy and prophylaxis of hyperglycemia
09/06/2005US6939853 Administering glucagon-like peptide 1 (GLP-1) compound and an effective amount of an antidyslipidemic drug for therapy of dyslipidemia
09/06/2005CA2243981C Food and vitamin preparations containing the natural isomer of reduced folates
09/06/2005CA2086137C Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same
09/03/2005CA2486341A1 Supplement foods and pharmaceuticals
09/01/2005WO2005080384A2 Benzimidazole derivative and use as aii receptor antagonist
09/01/2005WO2005080319A1 Hydrazino alcohol derivatives useful as inhibitors of copper-containing amine oxidases
09/01/2005WO2005079830A1 Inhibitors of amyloid fibril formation and uses thereof
09/01/2005WO2005079826A1 Soothing agent and food for treating fatigue
09/01/2005WO2005079824A1 Beverage or drug containing bamboo extract as main ingredient
09/01/2005WO2005079780A1 Amidine derivatives for treating amyloidosis
09/01/2005WO2004072282A9 Nephropathy-associated gene
09/01/2005WO2004048512A3 Novel proteins and nucleic acids encoding same
09/01/2005WO2003018759A3 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
09/01/2005WO2002083873A3 Enzymes
09/01/2005US20050192494 System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
09/01/2005US20050192335 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
09/01/2005US20050192334 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
09/01/2005US20050192332 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
09/01/2005US20050192327 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor
09/01/2005US20050192326 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril
09/01/2005US20050192318 5-[4-Methylsulfonyloxy-2-(S)-(3,4-dichlorophenyl)butyl]-10-cyano-3-(R)-methyl-6-oxo-3,4,5,6-tetrahydro-2H-benzo[b][1,5]oxazocine as antidepressant
09/01/2005US20050192307 Benzimidazolone compounds
09/01/2005US20050192306 Pyrimidine derivatives as selective inhibitors of COX-2
09/01/2005US20050192260 Pharmaceutical composition
1 ... 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 ... 1298